Alcohol, aldehydes, adducts and airways

Biomolecules

Volumn 5, Issue 4, 2015, Pages 2987-3008

  Sapkota, Muna ^a   Wyatt, Todd A ^a,b,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

Adducts; Alcohol; Aldehydes; Cigarette smoke; Lipid peroxidation; Lung; Reactive oxygen species

Indexed keywords

4 HYDROXYNONENAL; ACETALDEHYDE; ACROLEIN; ALBUMIN; ALCOHOL; ALCOHOL DEHYDROGENASE; ALDEHYDE; BUTYRALDEHYDE; COLLAGEN; CROTONALDEHYDE; CYSTEINE; CYTOCHROME P450 2E1; FORMALDEHYDE; GELATINASE B; GLUTATHIONE; HISTIDINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 6; INTERLEUKIN 8; ISOBUTYRALDEHYDE; LIPOPROTEIN; LYSINE; MALONALDEHYDE; PROPIONALDEHYDE; STRESS ACTIVATED PROTEIN KINASE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; TUBULIN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; DNA ADDUCT; PASSIVE SMOKING;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY; ALCOHOL ABUSE; ATHEROSCLEROSIS; BACTERIAL INFECTION; CHEMICAL REACTION; DISEASE ASSOCIATION; DNA ADDUCT; DNA DAMAGE; HUMAN; IMMUNE RESPONSE; LIPID PEROXIDATION; LUNG ALVEOLUS MACROPHAGE; LUNG DISEASE; LUNG LAVAGE; NONHUMAN; OXIDATIVE STRESS; PATHOLOGY; REVIEW; SMOKING; ADVERSE EFFECTS; ANIMAL; CHEMICALLY INDUCED; METABOLISM; PASSIVE SMOKING; RESPIRATORY TRACT DISEASE; TOXICITY;

ALDEHYDES; ANIMALS; DNA ADDUCTS; ETHANOL; HUMANS; RESPIRATORY TRACT DISEASES; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 84973617894     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom5042987     Document Type: Review

References (168)

1. Toews, G.B. Pulmonary defense mechanisms. Semin. Respir. Infect. 1993, 8, 160-167.
2. Nicod, L. Lung defences: An overview. Eur. Respir. Rev. 2005, 14, 45-50.
3. Zoltaszek, R.; Kowalczyk, P.; Kowalczyk, M.C.; Hanausek, M.; Kilianska, Z.M.; Slaga, T.J.; Walaszek, Z. Dietary D-glucarate effects on the biomarkers of inflammation during early post-initiation stages of benzo[a]pyrene-induced lung tumorigenesis in A/J mice. Oncol. Lett. 2011, 2, 145-154.
4. Hasani, A.; Pavia, D.; Spiteri, M.A.; Yeo, C.T.; Agnew, J.E.; Clarke, S.W.; Chung, K.F. Inhaled frusemide does not affect lung mucociliary clearance in healthy and asthmatic subjects. Eur. Respir. J. 1994, 7, 1497-1500.
5. Zaas, A.K.; Schwartz, D.A. Innate immunity and the lung: Defense at the interface between host and environment. Trends Cardiovasc. Med. 2005, 15, 195-202.
6. Bals, R. Epithelial antimicrobial peptides in host defense against infection. Respir. Res. 2000, 1, 141-150.
7. Azad, N.; Rojanasakul, Y.; Vallyathan, V. Inflammation and lung cancer: Roles of reactive oxygen/nitrogen species. J. Toxicol. Environ. Health Part B 2008, 11, 1-15.
8. Rosanna, D.P.; Salvatore, C. Reactive oxygen species, inflammation, and lung diseases. Curr. Pharm. Des. 2012, 18, 3889-3900.
9. Roberts, R.A.; Smith, R.A.; Safe, S.; Szabo, C.; Tjalkens, R.B.; Robertson, F.M. Toxicological and pathophysiological roles of reactive oxygen and nitrogen species. Toxicology 2010, 276, 85-94.
10. Rahman, I. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease. Cell Biochem. Biophys. 2005, 43, 167-188.
11. Bouchery, E.E.; Harwood, H.J.; Sacks, J.J.; Simon, C.J.; Brewer, R.D. Economic costs of excessive alcohol consumption in the US, 2006. Am. J. Prev. Med. 2011, 41, 516-524.
12. Gonzales, K.; Roeber, J.; Kanny, D.; Tran, A.; Saiki, C.; Johnson, H.; Yeoman, K.; Safranek, T.; Creppage, K.; Lepp, A. Alcohol-attributable deaths and years of potential life lost-11 States, 2006-2010. Morb. Mortal. Wkly. Rep. 2014, 63, 213-216.
13. Pearson, T.A. Alcohol and heart disease. Circulation 1996, 94, 3023-3025.
14. Moss, M.; Burnham, E.L. Alcohol abuse in the critically ill patient. Lancet 2007, 368, 2231-2242.
15. Allen, N.E.; Beral, V.; Casabonne, D.; Kan, S.W.; Reeves, G.K.; Brown, A.; Green, J. Moderate alcohol intake and cancer incidence in women. J. Natl. Cancer Inst. 2009, 101, 296-305.
16. Brown, L.A.S.; Cook, R.T.; Jerrells, T.R.; Kolls, J.K.; Nagy, L.E.; Szabo, G.; Wands, J.R.; Kovacs, E.J. Acute and chronic alcohol abuse modulate immunity. Alcohol. Clin. Exp. Res. 2006, 30, 1624-1631.
17. Liang, Y.; Yeligar, S.M.; Brown, L.A.S. Chronic-alcohol-abuse-induced oxidative stress in the development of acute respiratory distress syndrome. Sci. World J. 2012, doi:10.1100/2012/740308.
18. Jones, A.W. Excretion of alcohol in urine and diuresis in healthy men in relation to their age, the dose administered and the time after drinking. Forensic Sci. Int. 1990, 45, 217-224.
19. Kalant, H. Absorption, diffusion, distribution, and elimination of ethanol: Effects on biological membranes. In The biology of alcoholism ; Springer US: New York, NY, USA, 1971; pp. 1-62.
20. Sisson, J.H. Alcohol and airways function in health and disease. Alcohol 2007, 41, 293-307.
21. Hlastala, M.P.; Anderson, J.C. The impact of breathing pattern and lung size on the alcohol breath test. Annu. Biomed. Eng. 2007, 35, 264-272.
22. Kershaw, C.D.; Guidot, D.M. Alcoholic lung disease. Alcohol Res. Health 2008, 31, 66-75.
23. Jong, G.; Hsiue, T.; Chen, C.; Chang, H.; Chen, C. Rapidly fatal outcome of bacteremic Klebsiella pneumoniae pneumonia in alcoholics. CHEST J. 1995, 107, 214-217.
24. Molina, P.E.; Happel, K.I.; Zhang, P.; Kolls, J.K.; Nelson, S. Focus on: Alcohol and the immune system. Alcohol Res. Health 2010, 33, 97-108.
25. Sachs, C.W.; Christensen, R.H.; Pratt, P.C.; Lynn, W.S. Neutrophil elastase activity and superoxide production are diminished in neutrophils of alcoholics. Am. Rev. Respir. Dis. 1990, 141, 1249-1255.
26. Guidot, D.M.; Modelska, K.; Lois, M.; Jain, L.; Moss, I.M.; Pittet, J.F.; Brown, L.A. Ethanol ingestion via glutathione depletion impairs alveolar epithelial barrier function in rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279, L127-L135.
27. Guidot, D.; Moss, M.; Holguin, F.; Lois, M.; Brown, L. Ethanol ingestion impairs alveolar epithelial glutathione homeostasis and function, and predisposes to endotoxin-mediated acute lung injury. CHEST J. 1999, doi:10.1378/chest.116.suppl_1.82S.
28. Birt, J.E.C.; Shuker, D.E.; Farmer, P.B. Stable acetaldehyde-protein adducts as biomarkers of alcohol exposure. Chem. Res. Toxicol. 1998, 11, 136-142.
29. Centers for Disease Control and Prevention (CDC). Current cigarette smoking among adults-United States, 2011. Morb. Mortal. Wkly. Rep. 2012, 61, 889-894.
30. Blot, W.J.; McLaughlin, J.K.; Winn, D.M.; Austin, D.F.; Greenberg, R.S.; Preston-Martin, S.; Bernstein, L.; Schoenberg, J.B.; Stemhagen, A.; Fraumeni, J.F., Jr. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988, 48, 3282-3287.
31. Newcomb, P.A.; Carbone, P.P. The health consequences of smoking. Cancer. Med. Clin. North Am. 1992, 76, 305-331.
32. Sasco, A.; Secretan, M.; Straif, K. Tobacco smoking and cancer: A brief review of recent epidemiological evidence. Lung Cancer 2004, 45, S3-S9.
33. Egleston, B.L.; Meireles, S.I.; Flieder, D.B.; Clapper, M.L. Population-based trends in lung cancer incidence in women. Semin. Oncol. 2009, 36, 506-515.
34. Lopez, A.D.; Collishaw, N.E.; Piha, T. A descriptive model of the cigarette epidemic in developed countries. Tob. Control 1994, 3, 242-247.
35. Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US). How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease ; A Report of the Surgeon General: Atlanta, GA, USA, 2010.
36. Hecht, S.S. Cigarette smoking and lung cancer: Chemical mechanisms and approaches to prevention. Lancet Oncol. 2002, 3, 461-469.
37. Phillips, D.H. DNA adducts in human tissues: Biomarkers of exposure to carcinogens in tobacco smoke. Environ. Health Perspect. 1996, 104, 453-458.
38. Van der Vaart, H.; Postma, D.S.; Timens, W.; ten Hacken, N.H. Acute effects of cigarette smoke on inflammation and oxidative stress: A review. Thorax 2004, 59, 713-721.
39. Munnia, A.; Bonassi, S.; Verna, A.; Quaglia, R.; Pelucco, D.; Ceppi, M.; Neri, M.; Buratti, M.; Taioli, E.; Garte, S. Bronchial malondialdehyde DNA adducts, tobacco smoking, and lung cancer. Free Radic. Biol. Med. 2006, 41, 1499-1505.
40. RafiqKhan, M.; Sellappa, S. Serum malondialdehyde levels in lung cancer patients. J. Appl. Biol. Biotechnol. 2013, 1, 032-034.
41. Behr, J.; Nowak, D. Tobacco smoke and respiratory disease. Eur. Respair. Mon. 2002, 21, 161-179.
42. Hunninghake, G.W.; Crystal, R.G. Cigarette smoking and lung destruction: Accumulation of neutrophils in the lungs of cigarette smokers 1, 2. Am. Rev. Respir. Dis. 1983, 128, 833-838.
43. Shapiro, S.D. The macrophage in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999, 160, S29-S32.
44. Galvin, J.R.; Franks, T.J. Smoking-related lung disease. J. Thorac. Imaging 2009, 24, 274-284.
45. Yao, H.; Rahman, I. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. Toxicol. Appl. Pharmacol. 2011, 254, 72-85.
46. Fujioka, K.; Shibamoto, T. Determination of toxic carbonyl compounds in cigarette smoke. Environ. Toxicol. 2006, 21, 47-54.
47. Rahman, I. The role of oxidative stress in the pathogenesis of COPD. Treat. Respir. Med. 2005, 4, 175-200.
48. Valavanidis, A.; Vlachogianni, T.; Fiotakis, K.; Loridas, S. Pulmonary oxidative stress, inflammation and cancer: Respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanisms. Int. J. Environ. Res. Public Health 2013, 10, 3886-3907.
49. Hiura, T.S.; Kaszubowski, M.P.; Li, N.; Nel, A.E. Chemicals in diesel exhaust particles generate reactive oxygen radicals and induce apoptosis in macrophages. J. Immunol. 1999, 163, 5582-5591.
50. Frampton, M.W.; Pryor, W.A.; Cueto, R.; Cox, C.; Morrow, P.E.; Utell, M.J. Ozone exposure increases aldehydes in epithelial lining fluid in human lung. Am. J. Respir. Crit. Care Med. 1999, 159, 1134-1137.
51. Gardi, C.; Valacchi, G. Cigarette smoke and ozone effect on murine inflammatory responses. Ann. N. Y. Acad. Sci. 2012, 1259, 104-111.
52. Sunil, V.R.; Patel-Vayas, K.; Shen, J.; Laskin, J.D.; Laskin, D.L. Classical and alternative macrophage activation in the lung following ozone-induced oxidative stress. Toxicol. Appl. Pharmacol. 2012, 263, 195-202.
53. Lodovici, M.; Bigagli, E. Oxidative stress and air pollution exposure. J. Toxicol. 2011, doi:10.1155/2011/487074.
54. Kaphalia, L.; Calhoun, W.J. Alcoholic lung injury: Metabolic, biochemical and immunological aspects. Toxicol. Lett. 2013, 222, 171-179.
55. Matsuse, H.; Fukushima, C.; Shimoda, T.; Asai, S.; Kohno, S. Effects of Acetaldehyde on human airway constriction and inflammation. In Novartis Foundation Symposium ; John Wiley: New York, NY, USA, 2007; Volume 285, p. 97.
56. Aytacoglu, B.N.; Calikoglu, M.; Tamer, L.; Coskun, B.; Sucu, N.; Kose, N.; Aktas, S.; Dikmengil, M. Alcohol-induced lung damage and increased oxidative stress. Respiration 2006, 73, 100-104.
57. Hukkanen, J.; Pelkonen, O.; Hakkola, J.; Raunio, H. Expression and regulation of xenobioticmetabolizing cytochrome P450 (CYP) enzymes in human lung. Crit. Rev. Toxicol. 2002, 32, 391-411.
58. Kaphalia, L.; Boroumand, N.; Hyunsu, J.; Kaphalia, B.S.; Calhoun, W.J. Ethanol metabolism, oxidative stress, and endoplasmic reticulum stress responses in the lungs of hepatic alcohol dehydrogenase deficient deer mice after chronic ethanol feeding. Toxicol. Appl. Pharmacol. 2014, 277, 109-117.
59. Vasiliou, V.; Zakhari, S.; Seitz, H.K.; Hoek, J.B. Biological Basis of Alcohol-Induced Cancer ; Springer: New York, NY, USA, 2015.
60. Zheng, R.; Dragomir, A.; Mishin, V.; Richardson, J.R.; Heck, D.E.; Laskin, D.L.; Laskin, J.D. Differential metabolism of 4-hydroxynonenal in liver, lung and brain of mice and rats. Toxicol. Appl. Pharmacol. 2014, 279, 43-52.
61. Hoberman, H.D.; George, R.C.S. Reaction of tobacco smoke aldehydes with human hemoglobin. J. Biochem. Toxicol. 1988, 3, 105-119.
62. Piadé, J.; Wajrock, S.; Jaccard, G.; Janeke, G. Formation of mainstream cigarette smoke constituents prioritized by the World Health Organization-Yield patterns observed in market surveys, clustering and inverse correlations. Food Chem. Toxicol. 2013, 55, 329-347.
63. Chepiga, T.; Morton, M.; Murphy, P.; Avalos, J.; Bombick, B.; Doolittle, D.; Borgerding, M.; Swauger, J. A comparison of the mainstream smoke chemistry and mutagenicity of a representative sample of the US cigarette market with two Kentucky reference cigarettes (K1R4F and K1R5F). Food Chem. Toxicol. 2000, 38, 949-962.
64. International Agency for Research on Cancer (IARC). Allil Compounds, Aldehydes, Epoxides and Peroxides ; International Agency for Research on Cancer: Lyon, France, 1985; Volume 36.
65. Tuma, J.; Casey, C.A. Dangerous byproducts of alcohol breakdown-focus on adducts. Alcohol Res. Health 2003, 27, 285-290.
66. Corradi, M.; Rubinstein, I.; Andreoli, R.; Manini, P.; Caglieri, A.; Poli, D.; Alinovi, R.; Mutti, A. Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2003, 167, 1380-1386.
67. Salaspuro, V.; Salaspuro, M. Synergistic effect of alcohol drinking and smoking on in vivo acetaldehyde concentration in saliva. Int. J. Cancer 2004, 111, 480-483.
68. Pryor, W.A.; Bermúdez, E.; Cueto, R.; Squadrito, G.L. Detection of aldehydes in bronchoalveolar lavage of rats exposed to ozone. Toxicol. Sci. 1996, 34, 148-156.
69. Hecht, S.S. Smoking and lung cancer-A new role for an old toxicant? Proc. Natl. Acad. Sci. USA 2006, 103, 15725-15726.
70. Lodovici, M.; Bigagli, E. Biomarkers of induced active and passive smoking damage. Int. J. Environ. Res. Public Health 2009, 6, 874-888.
71. Phillips, D.H. Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 2002, 23, 1979-2004.
72. Araneda, O.; García, C.; Lagos, N.; Quiroga, G.; Cajigal, J.; Salazar, M.; Behn, C. Lung oxidative stress as related to exercise and altitude. Lipid peroxidation evidence in exhaled breath condensate: A possible predictor of acute mountain sickness. Eur. J. Appl. Physiol. 2005, 95, 383-390.
73. Mercken, E.M.; Hageman, G.J.; Schols, A.M.; Akkermans, M.A.; Bast, A.; Wouters, E.F. Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005, 172, 994-1001.
74. Wyatt, T.A.; Kharbanda, K.K.; McCaskill, M.L.; Tuma, D.J.; Yanov, D.; DeVasure, J.; Sisson, J.H. Malondialdehyde-acetaldehyde-adducted protein inhalation causes lung injury. Alcohol 2012, 46, 51-59.
75. Sherman, D.; Watson, R.R. Ethanol and the Liver: Mechanisms and Management ; CRC Press: Boca Raton, FL, USA, 2002.
76. Negre-Salvayre, A.; Coatrieux, C.; Ingueneau, C.; Salvayre, R. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br. J. Pharmacol. 2008, 153, 6-20.
77. Niedernhofer, L.J.; Daniels, J.S.; Rouzer, C.A.; Greene, R.E.; Marnett, L.J. Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J. Biol. Chem. 2003, 278, 31426-31433.
78. Negre-Salvayre, A.; Auge, N.; Ayala, V.; Basaga, H.; Boada, J.; Brenke, R.; Chapple, S.; Cohen, G.; Feher, J.; Grune, T. Pathological aspects of lipid peroxidation. Free Radic. Res. 2010, 44, 1125-1171.
79. Lee, S.E.; Park, Y.S. Role of lipid peroxidation-derived α, β-unsaturated aldehydes in vascular dysfunction. Oxid. Med. Cell. Longev. 2013, doi:10.1155/2013/629028.
80. Al-Rubaye, F.G. Correlation of serum Malonialdehyde Acetylaldehyde Adduct to serum Malondialdehyde as oxidative stress markers in Acute Coronary Syndrome patients. Indian J. Appl. Res. 2014, 4, 44-47.
81. Parola, M.; Bellomo, G.; Robino, G.; Barrera, G.; Dianzani, M.U. 4-Hydroxynonenal as a biological signal: Molecular basis and pathophysiological implications. Antioxid. Redox Signal. 1999, 1, 255-284.
82. Shimoda, T.; Kohno, S.; Takao, A.; Fujiwara, C.; Matsuse, H.; Sakai, H.; Watanabe, T.; Hara, K.; Asai, S. Investigation of the mechanism of alcohol-induced bronchial asthma. J. Allergy Clin. Immunol. 1996, 97, 74-84.
83. McConnell, E. Emergency and Continuous Exposure Guidance Levels for Selected Submarine Contaminants: Volume, 1. The National Academies Press: Washington, DC, USA, 2007; pp. 195-208.
84. Moretto, N.; Facchinetti, F.; Southworth, T.; Civelli, M.; Singh, D.; Patacchini, R. α, β-Unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through mitogen-activated protein kinases. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 296, L839-L848.
85. Facchinetti, F.; Amadei, F.; Geppetti, P.; Tarantini, F.; di Serio, C.; Dragotto, A.; Gigli, P.M.; Catinella, S.; Civelli, M.; Patacchini, R. α, β-Unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. Am. J. Respir. Cell Mol. Biol. 2007, 37, 617-623.
86. Finkelstein, E.I.; Ruben, J.; Koot, C.W.; Hristova, M.; van der Vliet, A. Regulation of constitutive neutrophil apoptosis by the α, β-unsaturated aldehydes acrolein and 4-hydroxynonenal. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289, L1019-L1028.
87. Deshmukh, H.S.; Shaver, C.; Case, L.M.; Dietsch, M.; Wesselkamper, S.C.; Hardie, W.D.; Korfhagen, T.R.; Corradi, M.; Nadel, J.A.; Borchers, M.T. Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production. Am. J. Respir. Cell Mol. Biol. 2008, 38, 446-454.
88. Van der Toorn, M.; Smit-de Vries, M.P.; Slebos, D.J.; de Bruin, H.G.; Abello, N.; van Oosterhout, A.J.; Bischoff, R.; Kauffman, H.F. Cigarette smoke irreversibly modifies glutathione in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 293, L1156-L1162.
89. Shukla, S.D.; Lim, R.W. Epigenetic effects of ethanol on the liver and gastrointestinal system. Alcohol. Res. 2013, 35, 47-55.
90. Shukla, S.D.; Aroor, A.R. Epigenetic effects of ethanol on liver and gastrointestinal injury. World J. Gastroenterol. 2006, 12, 5265-5271.
91. Manzo-Avalos, S.; Saavedra-Molina, A. Cellular and mitochondrial effects of alcohol consumption. Int. J. Environ. Res. Public Health 2010, 7, 4281-4304.
92. Chen, D.; Fang, L.; Li, H.; Tang, M.S.; Jin, C. Cigarette smoke component acrolein modulates chromatin assembly by inhibiting histone acetylation. J. Biol. Chem. 2013, 288, 21678-21687.
93. Grimsrud, P.A.; Xie, H.; Griffin, T.J.; Bernlohr, D.A. Oxidative stress and covalent modification of protein with bioactive aldehydes. J. Biol. Chem. 2008, 283, 21837-21841.
94. Doorn, J.A.; Petersen, D.R. Covalent adduction of nucleophilic amino acids by 4-hydroxynonenal and 4-oxononenal. Chem. Biol. Interact. 2003, 143, 93-100.
95. Sisson, J.H.; Tuma, D.J.; Rennard, S.I. Acetaldehyde-mediated cilia dysfunction in bovine bronchial epithelial cells. Am. J. Physiol. 1991, 260, L29-L36.
96. Sultana, R.; Raju, B.S.S.; Sharma, V.; Reddanna, P.; Babu, P.P. Formation of acetaldehyde adducts of glutathione S-transferase A3 in the liver of rats administered alcohol chronically. Alcohol 2005, 35, 57-66.
97. Casini, A.; Cunningham, M.; Rojkind, M.; Lieber, C.S. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 1991, 13, 758-765.
98. Brenner, D.A.; Chojkier, M. Acetaldehyde increases collagen gene transcription in cultured human fibroblasts. J. Biol. Chem. 1987, 262, 17690-17695.
99. Niemelä, O.; Klajner, F.; Orrego, H.; Vidins, E.; Blendis, L.; Israel, Y. Antibodies against acetaldehyde-modified protein epitopes in human alcoholics. Hepatology 1987, 7, 1210-1214.
100. Niemelä, O. Distribution of ethanol-induced protein adducts in vivo : Relationship to tissue injury 1, 2. Free Radic. Biol. Med. 2001, 31, 1533-1538.
101. Xu, D.; Thiele, G.M.; Beckenhauer, J.L.; Klassen, L.W.; Sorrell, M.F.; Tuma, D.J. Detection of circulating antibodies to malondialdehyde-acetaldehyde adducts in ethanol-fed rats. Gastroenterology 1998, 115, 686-692.
102. VanderVeen, L.A.; Hashim, M.F.; Shyr, Y.; Marnett, L.J. Induction of frameshift and base pair substitution mutations by the major DNA adduct of the endogenous carcinogen malondialdehyde. Proc. Natl. Acad. Sci. USA 2003, 100, 14247-14252.
103. Marnett, L.J. Oxyradicals and DNA damage. Carcinogenesis 2000, 21, 361-370.
104. Riedel, F.; Goessler, U.; Hörmann, K. Alcohol-related diseases of the mouth and throat. Best Pract. Res. Clin. Gastroenterol. 2003, 17, 543-555.
105. Theruvathu, J.A.; Jaruga, P.; Nath, R.G.; Dizdaroglu, M.; Brooks, P.J. Polyamines stimulate the formation of mutagenic 1, N2-propanodeoxyguanosine adducts from acetaldehyde. Nucleic Acids Res. 2005, 33, 3513-3520.
106. Peluso, M.; Srivatanakul, P.; Munnia, A.; Jedpiyawongse, A.; Ceppi, M.; Sangrajrang, S.; Piro, S.; Boffetta, P. Malondialdehyde-deoxyguanosine adducts among workers of a Thai industrial estate and nearby residents. Environ. Health Perspect. 2010, 118, 55-59.
107. Wyatt, T.A.; Kharbanda, K.K.; Tuma, D.J.; Sisson, J.H. Malondialdehyde-acetaldehyde-adducted bovine serum albumin activates protein kinase C and stimulates interleukin-8 release in bovine bronchial epithelial cells. Alcohol 2001, 25, 159-166.
108. Wyatt, T.A.; Kharbanda, K.K.; Tuma, D.J.; Sisson, J.H.; Spurzem, J.R. Malondialdehydeacetaldehyde adducts decrease bronchial epithelial wound repair. Alcohol 2005, 36, 31-40.
109. McCaskill, M.L.; Kharbanda, K.K.; Tuma, D.J.; Reynolds, J.D.; DeVasure, J.M.; Sisson, J.H.; Wyatt, T.A. Hybrid malondialdehyde and acetaldehyde protein adducts form in the lungs of mice exposed to alcohol and cigarette smoke. Alcohol. Clin. Exp. Res. 2011, 35, 1106-1113.
110. Lopachin, R.M.; Decaprio, A.P. Protein adduct formation as a molecular mechanism in neurotoxicity. Toxicol. Sci. 2005, 86, 214-225.
111. Fenaille, F.; Guy, P.A.; Tabet, J. Study of protein modification by 4-hydroxy-2-nonenal and other short chain aldehydes analyzed by electrospray ionization tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 2003, 14, 215-226.
112. Cai, J.; Bhatnagar, A.; Pierce, W.M., Jr. Protein modification by acrolein: Formation and stability of cysteine adducts. Chem. Res. Toxicol. 2009, 22, 708-716.
113. Donohue, T.M.; Tuma, D.J.; Sorrell, M.F. Acetaldehyde adducts with proteins: Binding of [14 C] acetaldehyde to serum albumin. Arch. Biochem. Biophys. 1983, 220, 239-246.
114. Tuma, D.J.; Newman, M.R.; Donohue, T.M.; Sorrell, M.F. Covalent binding of acetaldehyde to proteins: Participation of lysine residues. Alcohol. Clin. Exp. Res. 1987, 11, 579-584.
115. Tuma, D.J.; Jennett, R.B.; Sorrell, M.F. The interaction of acetaldehyde with tubulina. Ann. N. Y. Acad. Sci. 1987, 492, 277-286.
116. Tuma, D.J.; Hoffman, T.; Sorrell, M.F. The chemistry of acetaldehyde-protein adducts. Alcohol Alcohol. Suppl. 1991, 1, 271-276.
117. Requena, J.R.; Fu, M.X.; Ahmed, M.U.; Jenkins, A.J.; Lyons, T.J.; Thorpe, S.R. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrol. Dial. Transplant. 1996, 11, 48-53.
118. Sorrell, M.F.; Tuma, D.J. The functional implications of acetaldehyde binding to cell constituentsa. Ann. N. Y. Acad. Sci. 1987, 492, 50-62.
119. Eiserich, J.P.; van der Vliet, A.; Handelman, G.J.; Halliwell, B.; Cross, C.E. Dietary antioxidants and cigarette smoke-induced biomolecular damage: A complex interaction. Am. J. Clin. Nutr. 1995, 62, 1490S-1500S.
120. Uchida, K.; Stadtman, E.R. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc. Natl. Acad. Sci. USA 1992, 89, 4544-4548.
121. Novitskiy, G.; Ravi, R.; Potter, J.J.; Rennie-Tankersley, L.; Wang, L.; Mezey, E. Effects of acetaldehyde and TNFα on the inhibitory kappa B-α protein and nuclear factor kappa B activation in hepatic stellate cells. Alcohol Alcohol. 2005, 40, 96-101.
122. Kirichenko, A.; Li, L.; Morandi, M.T.; Holian, A. 4-Hydroxy-2-nonenal-protein adducts and apoptosis in murine lung cells after acute ozone exposure. Toxicol. Appl. Pharmacol. 1996, 141, 416-424.
123. Patel, V.B.; Worrall, S.; Emery, P.W.; Preedy, V.R. Protein adduct species in muscle and liver of rats following acute ethanol administration. Alcohol Alcohol. 2005, 40, 485-493.
124. Barrera, G.; Pizzimenti, S.; Ciamporcero, E.S.; Daga, M.; Ullio, C.; Arcaro, A.; Cetrangolo, G.P.; Ferretti, C.; Dianzani, C.; Lepore, A. Role of 4-hydroxynonenal-protein adducts in human diseases. Antioxid. Redox Signal. 2014, 22, 1681-1702.
125. Shamoto-Nagai, M.; Maruyama, W.; Hashizume, Y.; Yoshida, M.; Osawa, T.; Riederer, P.; Naoi, M. In parkinsonian substantia nigra, α-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity. J. Neural Transm. 2007, 114, 1559-1567.
126. Uchida, K.; Kanematsu, M.; Sakai, K.; Matsuda, T.; Hattori, N.; Mizuno, Y.; Suzuki, D.; Miyata, T.; Noguchi, N.; Niki, E.; et al. Protein-bound acrolein: Potential markers for oxidative stress. Proc. Natl. Acad. Sci. USA 1998, 95, 4882-4887.
127. Moretto, N.; Volpi, G.; Pastore, F.; Facchinetti, F. Acrolein effects in pulmonary cells: Relevance to chronic obstructive pulmonary disease. Ann. N. Y. Acad. Sci. 2012, 1259, 39-46.
128. Chavez, J.; Chung, W.; Miranda, C.L.; Singhal, M.; Stevens, J.F.; Maier, C.S. Site-specific protein adducts of 4-hydroxy-2(E)-nonenal in human THP-1 monocytic cells: Protein carbonylation is diminished by ascorbic acid. Chem. Res. Toxicol. 2009, 23, 37-47.
129. Niemelä, O.; Parkkila, S.; Pasanen, M.; Limuro, Y.; Bradford, B.; Thurman, R.G. Early alcoholic liver injury: Formation of protein adducts with acetaldehyde and lipid peroxidation products, and expression of CYP2E1 and CYP3A. Alcohol. Clin. Exp. Res. 1998, 22, 2118-2124.
130. Li, C.; Nanji, A.A.; Siakotos, A.N.; Lin, R.C. Acetaldehyde-modified and 4-hydroxynonenal-modified proteins in the livers of rats with alcoholic liver disease. Hepatology 1997, 26, 650-657.
131. Kirkham, P.A.; Caramori, G.; Casolari, P.; Papi, A.A.; Edwards, M.; Shamji, B.; Triantaphyllopoulos, K.; Hussain, F.; Pinart, M.; Khan, Y. Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2011, 184, 796-802.
132. Sampey, B.P.; Stewart, B.J.; Petersen, D.R. Ethanol-induced modulation of hepatocellular extracellular signal-regulated kinase-1/2 activity via 4-hydroxynonenal. J. Biol. Chem. 2007, 282, 1925-1937.
133. Wagner, T.M.; Mullally, J.E.; Fitzpatrick, F.A. Reactive lipid species from cyclooxygenase-2 inactivate tumor suppressor LKB1/STK11: Cyclopentenone prostaglandins and 4-hydroxy-2-nonenal covalently modify and inhibit the AMP-kinase kinase that modulates cellular energy homeostasis and protein translation. J. Biol. Chem. 2006, 281, 2598-2604.
134. Parola, M.; Robino, G.; Marra, F.; Pinzani, M.; Bellomo, G.; Leonarduzzi, G.; Chiarugi, P.; Camandola, S.; Poli, G.; Waeg, G.; et al. HNE interacts directly with JNK isoforms in human hepatic stellate cells. J. Clin. Investig. 1998, 102, 1942-1950.
135. Schutt, F.; Bergmann, M.; Holz, F.G.; Kopitz, J. Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium. Investig. Ophthalmol. Vis. Sci. 2003, 44, 3663-3668.
136. Wang, M.; McIntee, E.J.; Cheng, G.; Shi, Y.; Villalta, P.W.; Hecht, S.S. Identification of DNA adducts of acetaldehyde. Chem. Res. Toxicol. 2000, 13, 1149-1157.
137. Vaca, C.E.; Fang, J.; Schweda, E.K. Studies of the reaction of acetaldehyde with deoxynucleosides. Chem. Biol. Interact. 1995, 98, 51-67.
138. Wang, M.; Yu, N.; Chen, L.; Villalta, P.W.; Hochalter, J.B.; Hecht, S.S. Identification of an acetaldehyde adduct in human liver DNA and quantitation as N 2-ethyldeoxyguanosine. Chem. Res. Toxicol. 2006, 19, 319-324.
139. Brooks, P.J.; Theruvathu, J.A. DNA adducts from acetaldehyde: Implications for alcohol-related carcinogenesis. Alcohol 2005, 35, 187-193.
140. Bono, R.; Romanazzi, V.; Munnia, A.; Piro, S.; Allione, A.; Ricceri, F.; Guarrera, S.; Pignata, C.; Matullo, G.; Wang, P. Malondialdehyde-deoxyguanosine adduct formation in workers of pathology wards: The role of air formaldehyde exposure. Chem. Res. Toxicol. 2010, 23, 1342-1348.
141. Blair, I.A. DNA adducts with lipid peroxidation products. J. Biol. Chem. 2008, 283, 15545-15549.
142. Linhart, K.; Glassen, K.; Peccerella, T.; Waldherr, R.; Linhart, H.; Bartsch, H.; Seitz, H.K. The generation of carcinogenic etheno-DNA adducts in the liver of patients with nonalcoholic fatty liver disease. Hepatobil. Surg. Nutr. 2015, 4, 117-123.
143. Hang, B. Formation and repair of tobacco carcinogen-derived bulky DNA adducts. J. Nucleic Acids 2010, doi:10.4061/2010/709521.
144. Chaudhary, A.K.; Nokubo, M.; Reddy, G.R.; Yeola, S.N.; Morrow, J.D.; Blair, I.A.; Marnett, L.J. Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver. Science 1994, 265, 1580-1582.
145. Wang, M.; Dhingra, K.; Hittelman, W.N.; Liehr, J.G.; de Andrade, M.; Li, D. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. Cancer Epidemiol. Biomark. Prev. 1996, 5, 705-710.
146. Zhang, Y.; Chen, S.Y.; Hsu, T.; Santella, R.M. Immunohistochemical detection of malondialdehyde-DNA adducts in human oral mucosa cells. Carcinogenesis 2002, 23, 207-211.
147. Munnia, A.; Amasio, M.E.; Peluso, M. Exocyclic malondialdehyde and aromatic DNA adducts in larynx tissues. Free Radic. Biol. Med. 2004, 37, 850-858.
148. Sapkota, M.; Hottor, T.K.; deVasure, J.M.; Wyatt, T.A.; McCaskill, M.L. Protective role of CYP2E1 inhibitor diallyl disulfide (DADS) on alcohol-induced malondialdehyde-deoxyguanosine (M1dG) adduct formation. Alcohol. Clin. Exp. Res. 2014, 38, 1550-1558.
149. Linhart, K.; Bartsch, H.; Seitz, H.K. The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts. Redox Biol. 2014, 3, 56-62.
150. Seitz, H.K.; Stickel, F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat. Rev. Cancer 2007, 7, 599-612.
151. Drobes, D.J. Concurrent alcohol and tobacco dependence: Mechanisms and treatment. Alcohol Res. Health 2002, 26, 136-142.
152. Miller, N.S.; Gold, M.S. Comorbid cigarette and alcohol addiction: Epidemiology and treatment. J. Addict. Dis. 1998, 17, 55-66.
153. Ström, K. Alcohol, smoking and lung disease. Addict. Biol. 1999, 4, 17-22.
154. Niemela, O. Aldehyde-protein adducts in the liver as a result of ethanol-induced oxidative stress. Front. Biosci. 1999, 4, D506-D513.
155. Tuma, D.J.; Kearley, M.L.; Thiele, G.M.; Worrall, S.; Haver, A.; Klassen, L.W.; Sorrell, M.F. Elucidation of reaction scheme describing malondialdehyde-acetaldehyde-protein adduct formation. Chem. Res. Toxicol. 2001, 14, 822-832.
156. Tuma, D.J. Role of malondialdehyde-acetaldehyde adducts in liver injury 1, 2. Free Radic. Biol. Med. 2002, 32, 303-308.
157. Worrall, S.; de Jersey, J.; Wilce, P.A. Comparison of the formation of proteins modified by direct and indirect ethanol metabolites in the liver and blood of rats fed the Lieber-DeCarli liquid diet. Alcohol Alcohol. 2000, 35, 164-170.
158. Berger, J.P.; Simet, S.M.; DeVasure, J.M.; Boten, J.A.; Sweeter, J.M.; Kharbanda, K.K.; Sisson, J.H.; Wyatt, T.A. Malondialdehyde-acetaldehyde (MAA) adducted proteins bind to scavenger receptor A in airway epithelial cells. Alcohol 2014, 48, 493-500.
159. Nkadi, P.O.; Merritt, T.A.; Pillers, D.M. An overview of pulmonary surfactant in the neonate: Genetics, metabolism, and the role of surfactant in health and disease. Mol. Genet. Metab. 2009, 97, 95-101.
160. Duryee, M.J.; Freeman, T.L.; Willis, M.S.; Hunter, C.D.; Hamilton, B.C., 3rd; Suzuki, H.; Tuma, D.J.; Klassen, L.W.; Thiele, G.M. Scavenger receptors on sinusoidal liver endothelial cells are involved in the uptake of aldehyde-modified proteins. Mol. Pharmacol. 2005, 68, 1423-1430.
161. De Winther, M.P.; van Dijk, K.W.; Havekes, L.M.; Hofker, M.H. Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 290-297.
162. Hill, G.E.; Miller, J.A.; Baxter, B.T.; Klassen, L.W.; Duryee, M.J.; Tuma, D.J.; Thiele, G.M. Association of malondialdehyde-acetaldehyde (MAA) adducted proteins with atherosclerotic-induced vascular inflammatory injury. Atherosclerosis 1998, 141, 107-116.
163. Rolla, R.; Vay, D.; Mottaran, E.; Parodi, M.; Traverso, N.; Aricó, S.; Sartori, M.; Bellomo, G.; Klassen, L.W.; Thiele, G.M. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease. Hepatology 2000, 31, 878-884.
164. Duryee, M.J.; Klassen, L.W.; Freeman, T.L.; Willis, M.S.; Tuma, D.J.; Thiele, G.M. Lipopolysaccharide is a cofactor for malondialdehyde-acetaldehyde adduc mediated cytokine/ chemokine release by rat sinusoidal liver endothelial and kupffer cells. Alcohol. Clin. Exp. Res. 2004, 28, 1931-1938.
165. Thiele, G.M.; Duryee, M.J.; Anderson, D.R.; Klassen, L.W.; Mohring, S.M.; Young, K.A.; Benissan-Messan, D.; Sayles, H.; Dusad, A.; Hunter, C.D. Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis. Arthritis Rheumatol. 2015, 67, 645-655.
166. Willis, M.S.; Klassen, L.W.; Tuma, D.J.; Sorrell, M.F.; Thiele, G.M. Adduction of soluble proteins with malondialdehyde-acetaldehyde (MAA) induces antibody production and enhances T-cell proliferation. Alcohol. Clin. Exp. Res. 2002, 26, 94-106.
167. Carson, J.S.; Xiong, W.; Dale, M.; Yu, F.; Duryee, M.J.; Anderson, D.R.; Thiele, G.M.; Baxter, B.T. Antibodies against malondialdehyde-acetaldehyde adducts can help identify patients with abdominal aortic aneurysm. J. Vasc. Surg. 2015, doi:10.1016/j.jvs.2014.08.117.
168. Kaur, I.; Katyal, A. Modification of mouse A2M B (620-792) and A2M N (168-230) by malondialdehyde and acetaldehyde attenuates the proteinase and TGF-β1 binding ability of A2MB. FEBS Lett. 2011, 585, 829-833.